Axsome Therapeutics (AXSM) announced that Susan Mahony, PhD, has been appointed to Axsome’s board of directors, effective immediately. Dr. Mahony most recently served on the board of directors of Horizon Therapeutics from 2019 until its acquisition by Amgen (AMGN) in October 2023.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AXSM:
- Axsome Therapeutics to Report Third Quarter 2023 Financial Results on November 6
- Biotech Alert: Searches spiking for these stocks today
- Axsome Therapeutics joins National Alliance on Mental Illness
- Axsome Therapeutics Joins the National Alliance on Mental Illness and Others Advocating for the Importance of Mental Health on Mental Illness Awareness Week
- Axsome Therapeutics Joins the Global Narcolepsy Community in Raising Awareness on World Narcolepsy Day
